Analyst Ratings for Sagimet Biosciences Inc (SGMT)
SGMT Rating Summary
SGMT Price Target Summary
- Highest: $35.00 (Citizens)
- Lowest: $8.00 (Barclays)
- Average: $26.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.25 (+385.2%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$26.25 (+385.2%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/3/2026 | Guggenheim | Seamus Fernandez | New Coverage | Buy (N/A) |
27.00 (N/A) |
6.23 (5.41) |
-13.16% | Details |
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Equalweight (N/A) |
8.00 (N/A) |
6.03 (5.41) |
-10.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
